Murray, Frank & Sailer LLP is investigating a class action lawsuit on behalf who purchased or otherwise acquired securities of IMPAX Laboratories, Inc. (NASDAQ: IPXL); (“IMPAX” or the “Company”) between May 5, 2004 and November 3, 2004, inclusive (the “Class Period”).

Join the Case

Murray, Frank & Sailer LLP has learned that the IMPAX postponed its “release of 2004 third quarter financial results to Tuesday, November 9, 2004 in order to allow its independent auditors more time to complete their review of the Company's third quarter financial statements, including the timing of certain customer credits on buproprion products marketed by a strategic partner.” On this news, IMPAX stock fell more than 22% on abnormally high trading volume, on November 4, 2004.

The deadline to join this potential action with Murray, Frank & Sailer LLP is January 11, 2005. If you would like information, please contact Eric J. Belfi at 1-800-497-8076 or at  [email protected].